Post

J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial

Johnson and Johnson (J&J) has announced positive data from the Phase III QUASAR maintenance trial for Tremfya (guselkumab) as a …

Faron Pharmaceuticals reports positive data from MDS trial

Faron Pharmaceuticals has announced initial positive data from the Phase II segment of the ongoing BEXMAB clinical trial of bexmarilimab …

GSK boasts win for depemokimab in asthma trials

GSK has announced positive data from two Phase III trials of its asthma candidate depemokimab. The pharma giant announced the drug …

Rila Therapeutics doses first cohort in Phase I CKD treatment trial

Rila Therapeutics has dosed the first cohort of subjects in a Phase I clinical trial of RLA-23174, a potential treatment …

Challenges in female infertility: a focus on unmet needs

Great progress has been made in the management of female infertility since the introduction of assisted reproductive technology, predominantly in …